Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Bungeon Nov 25, 2020 10:05am

160 Views

Post# 31968925

RE:RE:1,150

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
122,500 shares	122,500	0.175
103,500 shares	103,500	0.170
43,500 shares	43,500	0.165
304,000 shares	304,000	0.160
2,000 shares	2,000	0.155
102,000 shares	102,000	0.150
135,000 shares	135,000	0.145
122,000 shares	122,000	0.140
46,000 shares	46,000	0.135
24,000 shares	24,000	0.130

Level two quotes - Ask
Ask Price	Number of Shares
0.185	67,500	67,500 shares
0.190	60,500	60,500 shares
0.195	18,500	18,500 shares
0.200	22,000	22,000 shares
0.205	70,000	70,000 shares
0.210	33,500	33,500 shares
0.215	50,500	50,500 shares
0.220	87,500	87,500 shares
0.230	26,500	26,500 shares
0.235	20,000